Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02110992 · TERMINATED
Trial details
- NCT number
- NCT02110992
- Sponsor
- University of Cincinnati
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-03-29
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.